BACKGROUND, E2F-1 is a transcription factor that stimulates cellular prolif
eration and cell cycle progression from G(1) to S-phase. Somewhat paradoxic
ally, E2F-1 also has the properties of a tumor suppressor. Overexpression o
f E2F-1 has been shown to induce apoptosis in some cancer cells. In the cur
rent study, the effect of adenovirus-mediated E2F-1 gene transfer on human
melanoma cell growth was investigated.
METHODS. Two human melanoma cell lines, SK-MEL-28 (wild-type p53) and SK-ME
L-2 (mutant p53), were treated by mock infection, infection with a control
vector expressing the beta-galactosidase gene (Ad5CMV-LacZ), or infection w
ith a vector expressing E2F-1 (Ad5CMV-E2F-1) at a multiplicity of infection
of 100. Cell proliferation and viability were determined by WST-1 assay an
d trypan blue exclusion, respectively. Apoptosis was assessed by cell flow
cytometry and confirmed by cell morphology, in situ terminal deoxynucleotid
yl nick end labeling assay, and poly(ADP-ribose) polymerase cleavage assay.
RESULTS. Marked overexpression of E2F-1 was evident in both cell lines 24 h
ours after infection with Ad5CMVE2F-1 by Western blot analysis. E2F-1 overe
xpression resulted in growth inhibition and rapid loss of cell viability. O
verexpression of E2F-1 also resulted in premature S-phase entry and G(2) ar
rest at 24 hours followed by apoptotic cell death at 48 hours. After Ad5CMV
E2F-1 infection, expression of Bar and Bak was unchanged, whereas Mcl-1 lev
els decreased markedly. In SK-MEL-28 cells, Bcl-XL levels also declined aft
er E2F-1 expression. Bcl-2 was undetectable in SK-MEL-28 cells but was incr
eased in SK-MEL-2 cells in response to E2F-1 overexpression.
CONCLUSIONS. Adenovirus-mediated E2F-1 gene transfer efficiently induces wi
despread apoptosis in human melanoma cells. E2F-1 overexpression induced ap
optosis in cell lines containing wild-type and mutant p53, suggesting that
this effect does not require wild-type p53 function. Anti-apoptotic protein
s of the Bcl-2 family, notably Mcl-1 and Bcl-XL, may be involved in mediati
ng the response to E2F-1. These data suggest that adenovirus-mediated E2F-1
gene therapy may be effective in the treatment of melanoma. Cancer 1999;86
:2021-33. (C) 1999 American Cancer Society.